News

ImmuONE featured on ITV News

Gender equality in the biotech industry has come a long way in recent years. In the UK, the US and Europe, women now make up between 40-50% of the biotech workforce, which is a higher percentage than in other STEM fields, such as engineering and the physical sciences.

From microbiology to biotech: Meet Brendon

Brendon Ghiot, our Senior Scientist at ImmuONE, joins us for a coffee to share his diverse journey from working in cellular biology to pioneering in CAR-T therapy for cancer treatment. Brendon tells us what drives his interest in developing new technologies at ImmuONE, particularly in animal-free inhalation toxicity testing.

That’s a wrap for 2023!

New innovations, new research, new teammates, a new lab – and soon, a new year! Before we turn our attention to 2024, let’s take a step back and appreciate all we’ve achieved so far.

Highlights from ImmuONE’s  First Webinar  

ImmuONE made a significant stride on November 8th by hosting its first-ever webinar, ‘unveiling insights into the next generation of tools for inhalation risk assessment’. The webinar began with a glimpse into ImmuONE’s evolution, emphasizing key milestones and leadership perspectives, presented by Prof. Victoria Hutter.

Joining ImmuONE: Insights from Jo

In our most recent coffee chat, we caught up with Jo Kelsall, our new lead commercial scientist. Jo shared with us her unique career spanning the realms of science and law while also giving us the inside scoop on what life has been like so far at ImmuONE!

Scroll to Top